Johnson & Johnson (JNJ) Tops Q1 EPS by 1c

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.13, $0.01 better than the analyst estimate of $2.12. Revenue for the quarter came in at $24.8 billion versus the consensus estimate of $25.29 billion.

GUIDANCE:

Johnson & Johnson sees FY2022 EPS of $10.40-$10.60, versus the consensus of $10.37.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c